| 0 (0%) | 03-09 20:25 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 11.29  |
1-year : | 13.19 |
| Resists | First : | 9.67 |
Second : | 11.29 |
| Pivot price | 8.51 |
|||
| Supports | First : | 8.09 |
Second : | 7.12 |
| MAs | MA(5) : | 8.95 |
MA(20) : | 8.44 |
| MA(100) : | 6.73 |
MA(250) : | 6.19 |
|
| MACD | MACD : | 0.4 |
Signal : | 0.3 |
| %K %D | K(14,3) : | 86.5  |
D(3) : | 87.7 |
| RSI | RSI(14): 75.8 |
|||
| 52-week | High : | 9.67 | Low : | 4.85 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ PTEN ] has closed below upper band by 0.4%. Bollinger Bands are 28% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 9.08 - 9.12 | 9.12 - 9.15 |
| Low: | 8.61 - 8.65 | 8.65 - 8.69 |
| Close: | 8.89 - 8.97 | 8.97 - 9.03 |
Mon, 09 Mar 2026
Goldman Sachs Raises Patterson-UTI Energy, Inc. (PTEN) Price Target by $2 - Insider Monkey
Mon, 09 Mar 2026
Patterson-UTI Energy (NASDAQ:PTEN) Hits New 52-Week High - Should You Buy? - MarketBeat
Wed, 04 Mar 2026
PTEN as a Biomarker: Background and Clinical Significance - Urology Times
Tue, 03 Mar 2026
Patterson-UTI Energy (PTEN) Is Up 5.5% After Earnings Beat And Dividend Hike - What's Changed - simplywall.st
Fri, 13 Feb 2026
Neurologic Manifestations of PTEN Hamartoma Tumor Syndrome Get Their Due in First-Ever Guidelines - Cleveland Clinic
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 380 (M) |
| Shares Float | 344 (M) |
| Held by Insiders | 2.7 (%) |
| Held by Institutions | 114.6 (%) |
| Shares Short | 31,500 (K) |
| Shares Short P.Month | 24,740 (K) |
| EPS | -0.24 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 8.47 |
| Profit Margin | -2 % |
| Operating Margin | -2.5 % |
| Return on Assets (ttm) | -0.5 % |
| Return on Equity (ttm) | -2.8 % |
| Qtrly Rev. Growth | -1 % |
| Gross Profit (p.s.) | 3.08 |
| Sales Per Share | 12.72 |
| EBITDA (p.s.) | 2.37 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 961 (M) |
| Levered Free Cash Flow | 410 (M) |
| PE Ratio | -38.63 |
| PEG Ratio | 0 |
| Price to Book value | 1.09 |
| Price to Sales | 0.72 |
| Price to Cash Flow | 3.66 |
| Dividend | 0.1 |
| Forward Dividend | 0 |
| Dividend Yield | 1% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|